CSIMarket
 


Modular Medical Inc   (MODD)
Other Ticker:  
 

Modular Medical Inc 's Working Capital Ratio

MODD's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2023, Working Capital Ratio fell to 2.17 below Modular Medical Inc average.

Within Medical Equipment & Supplies industry 19 other companies have achieved higher Working Capital Ratio than Modular Medical Inc in third quarter 2023. While Working Capital Ratio total ranking has improved so far during the III Quarter 2023 to 337, from total ranking in the second quarter 2023 at 450.

Explain Working Capital Ratio
How much in Current Assets MODD´s has?
What is the value of MODD´s Current Liabilities?


MODD Working Capital Ratio (Dec 31 2023)
III. Quarter
(Sep 30 2023)
II. Quarter
(Jun 30 2023)
I. Quarter
(Mar 31 2023)
IV. Quarter
(Dec 31 2022)
III. Quarter
Y / Y Current Liabilities Change 68.91 % 31.21 % -20.2 % -24.34 % -92.85 %
Y / Y Current Assets Change -70.62 % -41.8 % -27.2 % -57.36 % 2067.8 %
Working Capital Ratio MRQ 2.17 8.48 15.25 6.48 12.5
MODD's Total Ranking # 337 # 450 # 317 # 797 # 134
Seq. Current Liabilities Change 41.34 % 13.56 % 7.52 % -2.12 % 9.79 %
Seq. Current Assets Change -63.76 % -36.85 % 152.95 % -49.24 % -28.22 %



Working Capital Ratio third quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 20
Healthcare Sector # 65
Overall Market # 337


Working Capital Ratio Statistics
High Average Low
278.29 41.61 0
(Mar 31 2018)   (Sep 30 2015)




Financial Statements
Modular Medical Inc 's Current Liabilities $ 1 Millions Visit MODD's Balance sheet
Modular Medical Inc 's Current Assets $ 2 Millions Visit MODD's Balance sheet
Source of MODD's Sales Visit MODD's Sales by Geography


Cumulative Modular Medical Inc 's Working Capital Ratio

MODD's Working Capital Ratio for the trailling 12 Months

MODD Working Capital Ratio

(Dec 31 2023)
III. Quarter
(Sep 30 2023)
II. Quarter
(Jun 30 2023)
I. Quarter
(Mar 31 2023)
IV. Quarter
(Dec 31 2022)
III. Quarter
Y / Y Current Liabilities TTM Growth 68.91 % 31.21 % -20.2 % -24.34 % -92.85 %
Y / Y Current Assets TTM Growth -70.62 % -41.8 % -27.2 % -57.36 % 2067.8 %
Working Capital Ratio TTM 7.37 10.66 13.27 13.86 14.78
Total Ranking TTM # 201 # 3772 # 3248 # 4035 # 26
Seq. Current Liabilities TTM Growth 41.34 % 13.56 % 7.52 % -2.12 % 9.79 %
Seq. Current Assets TTM Growth -63.76 % -36.85 % 152.95 % -49.24 % -28.22 %


On the trailing twelve months basis Due to jump in Current Liabilities in the III Quarter 2023 to $1.08 millions, cumulative Working Capital Ratio decreased to 7.37 below the Modular Medical Inc average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 12 other companies have achieved higher Working Capital Ratio than Modular Medical Inc . While Working Capital Ratio overall ranking has improved so far to 201, from total ranking during the twelve months ending second quarter 2023 at 3772.

Explain Working Capital Ratio
How much in Current Assets MODD´s has?
What is the value of MODD´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 13
Healthcare Sector # 42
Within the Market # 201


trailing twelve months Working Capital Ratio Statistics
High Average Low
205.11 31.85 0.27
(Jun 30 2018)   (Dec 31 2021)




Companies with similar Working Capital Ratio in the quarter ending Dec 31 2023, within Medical Equipment & Supplies Industry Working Capital RatioDec 31 2023 MRQ Current AssetsDec 31 2023 MRQ Current Liabilities
Electromed Inc   5.97 $ 39.265  Millions$ 6.573  Millions
Merit Medical Systems Inc  5.79 $ 1,108.470  Millions$ 191.477  Millions
Brainsway Ltd   5.68 $ 55.465  Millions$ 9.761  Millions
Tandem Diabetes Care Inc   5.57 $ 747.989  Millions$ 134.204  Millions
Apyx Medical Corporation  5.52 $ 70.362  Millions$ 12.740  Millions
Glaukos Corp  5.34 $ 395.461  Millions$ 74.014  Millions
Anika Therapeutics Inc   5.26 $ 163.309  Millions$ 31.059  Millions
Monogram Orthopaedics inc   5.19 $ 14.618  Millions$ 2.818  Millions
Nephros Inc   5.04 $ 8.405  Millions$ 1.667  Millions
Neuronetics inc   4.95 $ 93.793  Millions$ 18.967  Millions
Globus Medical Inc   4.88 $ 1,915.374  Millions$ 392.347  Millions
Clearpoint Neuro Inc   4.87 $ 36.172  Millions$ 7.430  Millions
Artivion Inc   4.85 $ 280.668  Millions$ 57.862  Millions
Intuitive Surgical Inc   4.76 $ 7,888.000  Millions$ 1,658.700  Millions
Koru Medical Systems Inc  4.55 $ 20.256  Millions$ 4.454  Millions
Bone Biologics Corporation  4.50 $ 3.738  Millions$ 0.831  Millions
Tela Bio Inc   4.23 $ 71.726  Millions$ 16.967  Millions
Endra Life Sciences Inc   4.16 $ 3.033  Millions$ 0.729  Millions
Star Equity Holdings Inc   3.99 $ 34.806  Millions$ 8.734  Millions
Helius Medical Technologies inc   3.96 $ 7.438  Millions$ 1.879  Millions
Aethlon Medical Inc   3.93 $ 8.249  Millions$ 2.101  Millions
Tactile Systems Technology Inc   3.80 $ 145.294  Millions$ 38.250  Millions
Dariohealth Corp   3.79 $ 47.330  Millions$ 12.493  Millions
Integra Lifesciences Holdings Corp  3.74 $ 1,058.036  Millions$ 283.156  Millions
Neuroone Medical Technologies Corporation  3.68 $ 5.093  Millions$ 1.383  Millions
Pro dex Inc   3.66 $ 36.600  Millions$ 9.990  Millions
Inovio Pharmaceuticals Inc   3.60 $ 153.113  Millions$ 42.570  Millions
Atricure Inc   3.57 $ 266.246  Millions$ 74.569  Millions
Mimedx Group Inc   3.57 $ 164.261  Millions$ 46.008  Millions
Insulet Corporation  3.51 $ 1,582.900  Millions$ 451.200  Millions

Date modified: 2024-02-14T09:26:02+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com